Serina Therapeutics
SER
48 hedge funds and large institutions have $4.88M invested in Serina Therapeutics in 2020 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 4 increasing their positions, 16 reducing their positions, and 15 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.09% less ownership
Funds ownership: 0.48% → 0.39% (-0.09%)
7% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 15
2% less funds holding
Funds holding: 49 → 48 (-1)
17% less capital invested
Capital invested by funds: $5.9M → $4.88M (-$1.02M)
75% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$201K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$130K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$126K |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$43.7K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$42.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$830K |
| 2 |
State Street
Boston,
Massachusetts
|
-$273K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$151K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$89.2K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$69.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Legal & General Group
London,
United Kingdom
| – | -$4K | -126 | Closed |
|
|
S
52
SignatureFD
Atlanta,
Georgia
| – | -$2K | -71 | Closed |
|
|
AIP
53
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$1K | -17 | Closed |
|
|
PAG
54
Private Advisor Group
Morristown,
New Jersey
| – | +$59 | +2 | New |
|
SER Hedge Fund Activity: Q2 2020 in Review
48 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q2 2020, worth a combined $4.88M — down 17% from $5.9M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of SER and 14 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 4 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $201K. The largest seller was BlackRock, cutting an estimated $830K.
- 48 institutional investors held Serina Therapeutics (SER) as of Q2 2020, down from 49 in Q1 2020.
- Funds reported $4.88M of Serina Therapeutics stock for Q2 2020, down 17% quarter-over-quarter.
- 14 funds opened new Serina Therapeutics positions in Q2 2020 and 15 closed out, a net change of -1 holder.
- The largest Serina Therapeutics buyer in Q2 2020 was Millennium Management, an estimated $201K added.
- The largest Serina Therapeutics seller in Q2 2020 was BlackRock, an estimated $830K sold.
Based on aggregated 13F filings for Q2 2020.